Citadel Advisors - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is and the CUSIP is 45253H951. A total of 2 filers reported holding IMMUNOGEN INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2016$42,000
-54.8%
13,600
+24.8%
0.00%
Q1 2016$93,000
+173.5%
10,900
+336.0%
0.00%
Q4 2015$34,000
-63.8%
2,500
-74.5%
0.00%
Q3 2015$94,000
-60.7%
9,800
-41.0%
0.00%
Q2 2015$239,000
+32.0%
16,600
-17.8%
0.00%
Q1 2015$181,000
-30.9%
20,200
-52.9%
0.00%
Q4 2014$262,000
+20.2%
42,900
+108.3%
0.00%
Q3 2014$218,000
-31.0%
20,600
-22.8%
0.00%
Q2 2014$316,000
+38.6%
26,700
+74.5%
0.00%
Q1 2014$228,000
-62.1%
15,300
-62.7%
0.00%
-100.0%
Q4 2013$601,000
+16.9%
41,000
+35.8%
0.00%0.0%
Q3 2013$514,000
+66.3%
30,200
+62.4%
0.00%0.0%
Q2 2013$309,00018,6000.00%
Other shareholders
IMMUNOGEN INC shareholders Q2 2013
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 413,300$6,559,0710.02%
JANE STREET GROUP, LLC 552,200$8,763,4140.00%
SIMPLEX TRADING, LLC 180,200$2,8590.00%
JPMORGAN CHASE & CO 4,400$69,8280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IMMUNOGEN INC shareholders